The time to first treatment is an independent predictor of overall survival in chronic lymphocytic leukemia

被引:0
|
作者
Morabito, Fortunato [1 ]
Tripepi, Giovanni [2 ]
Mauro, Francesca Romana [3 ]
Laurenti, Luca [4 ]
Reda, Gianluigi [5 ,6 ]
Moia, Riccardo [7 ]
Condoluci, Adalgisa [8 ,9 ]
Vincelli, Iolanda [10 ]
Chiarenza, Annalisa [11 ]
Vigna, Ernesto [12 ]
Martino, Enrica Antonia [12 ]
Bruzzese, Antonella
Mezzatesta, Sabrina [2 ]
Laureana, Roberta [13 ]
Cutrona, Giovanna [14 ]
Di Raimondo, Francesco
Fronza, Gilberto [15 ]
Zucchetto, Antonella [16 ]
Bomben, Riccardo [16 ]
Rossi, Francesca Maria [16 ]
Olivieri, Jacopo [17 ]
Zaja, Francesco [18 ]
Rossi, Davide [8 ,9 ]
Gaidano, Gianluca [7 ]
Del Principe, Maria Ilaria [13 ]
Ilariucci, Fiorella [19 ]
Del Poeta, Giovanni [13 ]
Ferrarini, Manlio [14 ]
Neri, Antonino [20 ]
Gattei, Valter [16 ]
Gentile, Massimo [12 ,21 ]
机构
[1] AO ASP Cosenza, Biotechnol Res Unit, Aprigliano, I-87100 Cosenza, Italy
[2] CNR, Ist Fisiol Clin CNR, Reggio Di Calabria, Italy
[3] Sapienza Univ, Dept Cellular Biotechnol & Hematol, Rome, Italy
[4] Catholic Univ Hosp A Gemelli Rome, Dept Hematol, Rome, Italy
[5] Univ Milan, Dept Oncol & Hematooncol, Milan, Italy
[6] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Hematol CTMO, Milan, Italy
[7] Univ Piemonte Orientale, Dept Translat Med, Div Haematol, Novara, Italy
[8] Oncol Inst Southern Switzerland, Bellinzona, Switzerland
[9] Inst Oncol Res, Bellinzona, Switzerland
[10] Hematol Unit Reggio Calabria, Reggio Di Calabria, Italy
[11] Univ Catania, Osped Ferrarotto, Div Ematol, Catania, Italy
[12] AO Cosenza, Dept Oncohematol, Hematol Unit, Cosenza, Italy
[13] Univ Roma Tor Vergata, Dipartimento Biomed & Prevenz, Ematol, Rome, Italy
[14] Osped Policlin San Martino IRCCS, UO Mol Pathol, Genoa, Italy
[15] IRCCS Osped Policlin San Martino, Mutagenesis & Canc Prevent Unit, Genoa, Italy
[16] Ctr Riferimento Oncol Aviano CRO IRCCS, Clin & Expt Onco Hematol Unit, Aviano, Italy
[17] Azienda Osped Univ S Maria Misericordia, Ctr Trapianti & Terapie Cellulari, Clin Ematol, Udine, Italy
[18] Univ Trieste, Haematol, Trieste, Italy
[19] Azienda USL IRCCS Reggio Emilia, Hematol Unit, Reggio Emilia, Italy
[20] Azienda USL IRCCS Reggio Emilia, Sci Directorate, Reggio Emilia, Italy
[21] Univ Calabria, Dept Pharm Hlth & Nutr Sci, Arcavacata Di Rende, Italy
基金
瑞士国家科学基金会; 欧洲研究理事会;
关键词
PROGRESSION; RISK;
D O I
10.1002/ajh.26927
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E157 / E160
页数:4
相关论文
共 50 条
  • [1] Serum soluble CD23 levels are an independent predictor of time to first treatment in chronic lymphocytic leukemia
    Pineyroa, Juan A.
    Magnano, Laura
    Rivero, Andrea
    Rivas-Delgado, Alfredo
    Nadeu, Ferran
    Correa, Juan Gonzalo
    Gine, Eva
    Villamor, Neus
    Filella, Xavier
    Colomer, Dolors
    Lopez, Monica
    Lopez-Oreja, Irene
    Costa, Dolors
    Aymerich, Marta
    Bea, Silvia
    Lopez-Guillermo, Armando
    Campo, Elias
    Delgado, Julio
    Mozas, Pablo
    HEMATOLOGICAL ONCOLOGY, 2022, 40 (04) : 588 - 595
  • [2] Cytomegalovirus infection does not impact on survival or time to first treatment in patients with chronic lymphocytic leukemia
    Parry, Helen Marie
    Damery, Sarah
    Hudson, Christopher
    Maurer, Matthew J.
    Cerhan, James R.
    Pachnio, Annette
    Begum, Jusnara
    Slager, Susan L.
    Fegan, Christopher
    Man, Stephen
    Pepper, Christopher
    Shanafelt, Tait D.
    Pratt, Guy
    Moss, Paul A. H.
    AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (08) : 776 - 781
  • [3] Multivariable Model for Time to First Treatment in Patients With Chronic Lymphocytic Leukemia
    Wierda, William G.
    O'Brien, Susan
    Wang, Xuemei
    Faderl, Stefan
    Ferrajoli, Alessandra
    Do, Kim-Anh
    Garcia-Manero, Guillermo
    Cortes, Jorge
    Thomas, Deborah
    Koller, Charles A.
    Burger, Jan A.
    Lerner, Susan
    Schlette, Ellen
    Abruzzo, Lynne
    Kantarjian, Hagop M.
    Keating, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (31) : 4088 - 4095
  • [4] Chronic Lymphocytic Leukemia Prognostic Index: A New Integrated Scoring System to Predict the Time to First Treatment in Chinese Patients with Chronic Lymphocytic Leukemia
    Li, Heng
    Yi, Shu-Hua
    Xiong, Wen-Jie
    Liu, Hui-Min
    Lyu, Rui
    Wang, Ting-Yu
    Liu, Wei
    Zhong, Shi-Zhen
    Yu, Zhen
    Zou, De-Hui
    Xu, Yan
    An, Gang
    Li, Zeng-Jun
    CHINESE MEDICAL JOURNAL, 2017, 130 (02) : 135 - U14
  • [5] An eight-gene expression signature for the prediction of survival and time to treatment in chronic lymphocytic leukemia
    Herold, T.
    Jurinovic, V.
    Metzeler, K. H.
    Boulesteix, A-L
    Bergmann, M.
    Seiler, T.
    Mulaw, M.
    Thoene, S.
    Dufour, A.
    Pasalic, Z.
    Schmidberger, M.
    Schmidt, M.
    Schneider, S.
    Kakadia, P. M.
    Feuring-Buske, M.
    Braess, J.
    Spiekermann, K.
    Mansmann, U.
    Hiddemann, W.
    Buske, C.
    Bohlander, S. K.
    LEUKEMIA, 2011, 25 (10) : 1639 - 1645
  • [6] Vitamin D insufficiency predicts time to first treatment (TFT) in early chronic lymphocytic leukemia (CLL)
    Molica, Stefano
    Digiesi, Giovanna
    Antenucci, Anna
    Levato, Luciano
    Mirabelli, Rosanna
    Molica, Matteo
    Gentile, Massimo
    Giannarelli, Diana
    Sperduti, Isabella
    Morabito, Fortunato
    Conti, Laura
    LEUKEMIA RESEARCH, 2012, 36 (04) : 443 - 447
  • [7] External validation on a prospective basis of a nomogram for predicting the time to first treatment in patients with chronic lymphocytic leukemia
    Molica, Stefano
    Giannarelli, Diana
    Gentile, Massimo
    Cutrona, Giovanna
    Di Renzo, Nicola
    Di Raimondo, Francesco
    Neri, Antonino
    Federico, Massimo
    Ferrrarini, Manlio
    Morabito, Fortunato
    CANCER, 2013, 119 (06) : 1177 - 1185
  • [8] Time to Second-line Treatment and Subsequent Relative Survival in Older Patients With Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
    Ammann, Eric M.
    Shanafelt, Tait D.
    Larson, Melissa C.
    Wright, Kara B.
    McDowell, Bradley D.
    Link, Brian K.
    Chrischilles, Elizabeth A.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (12) : E11 - E25
  • [9] Epstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival
    Ferrajoli, Alessandra
    Ivan, Cristina
    Ciccone, Maria
    Shimizu, Masayoshi
    Kita, Yoshiaki
    Ohtsuka, Masahisha
    D'Abundo, Lucilla
    Qiang, Jun
    Lerner, Susan
    Nouraee, Nazila
    Rabe, Kari G.
    Rassenti, Laura Z.
    Van Roosbroeck, Katrien
    Manning, John T.
    Yuan, Yuan
    Zhang, Xinna
    Shanafelt, Tait D.
    Wierda, William G.
    Sabbioni, Silvia
    Tarrand, Jeffrey J.
    Estrov, Zeev
    Radovich, Milan
    Liang, Han
    Negrini, Massimo
    Kipps, Thomas J.
    Kay, Neil E.
    Keating, Michael
    Calina, George A.
    EBIOMEDICINE, 2015, 2 (06): : 572 - 582
  • [10] The chronic lymphocytic leukemia international prognostic index predicts time to first treatment in early CLL: Independent validation in a prospective cohort of early stage patients
    Molica, Stefano
    Shanafelt, Tait D.
    Giannarelli, Diana
    Gentile, Massimo
    Mirabelli, Rosanna
    Cutrona, Giovanna
    Levato, Luciano
    Di Renzo, Nicola
    Di Raimondo, Francesco
    Musolino, Caterina
    Angrilli, Francesco
    Fama, Angelo
    Recchia, Anna Grazia
    Chaffee, Kari G.
    Neri, Antonino
    Kay, Neil E.
    Ferrarini, Manlio
    Morabito, Fortunato
    AMERICAN JOURNAL OF HEMATOLOGY, 2016, 91 (11) : 1090 - 1095